Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture

(2011) R. S. Choung et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The intestinal microbiota and chronic disorders of the gut

(2011) Andrew W. DuPont et al.   Nature Reviews Gastroenterology & Hepatology

The Search for Effective Treatment ofClostridium difficileInfection

(2011) Herbert L. DuPont   NEW ENGLAND JOURNAL OF MEDICINE

Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection

(2010) Michael D. Howell   ARCHIVES OF INTERNAL MEDICINE

Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection

(2010) Amy Linsky   ARCHIVES OF INTERNAL MEDICINE

Failing the Acid Test

(2010) Mitchell H. Katz   ARCHIVES OF INTERNAL MEDICINE

Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study

(2010) Y. DOORDUYN et al.   EPIDEMIOLOGY AND INFECTION

Clostridium difficile infection in an endemic setting in the Netherlands

(2010) M. P. M. Hensgens et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Proton pump inhibitors as a risk factor for recurrence ofClostridium-difficile-associated diarrhea

(2010) Ji Won Kim   WORLD JOURNAL OF GASTROENTEROLOGY

Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI

(2009) Joel J Heidelbaugh et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Examination of Potential Mechanisms To Explain the Association between Proton Pump Inhibitors and Clostridium difficile Infection

(2009) M. M. Nerandzic et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gastric acid reduction leads to an alteration in lower intestinal microflora

(2009) Takayuki Kanno et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors

(2009) S.B. Debast et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effects of Proton Pump Inhibitors on Gastric Emptying: A Systematic Review

(2009) Masaki Sanaka et al.   DIGESTIVE DISEASES AND SCIENCES

Expert Review of the Evidence Base for Prevention of Travelers’ Diarrhea

(2009) Herbert L. DuPont et al.   JOURNAL OF TRAVEL MEDICINE

Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase

(2008) J. M. MULLIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Proton pump inhibitors increase significantly the risk ofClostridium difficileinfection in a low-endemicity, non-outbreak hospital setting

(2008) B. R. DALTON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clostridium difficileColitis: Wash Your Hands Before Stopping the Proton Pump Inhibitor

(2008) David C. Metz   AMERICAN JOURNAL OF GASTROENTEROLOGY

Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor forClostridium Difficile-Associated Diarrhea in Hospitalized Patients

(2008) Mohammed Aseeri et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Differences in Survival among 13 Listeria monocytogenes Strains in a Dynamic Model of the Stomach and Small Intestine

(2008) I. M. Barmpalia-Davis et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

(2008) S. Dial et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Gastric secretion

(2008) Mitchell L Schubert   CURRENT OPINION IN GASTROENTEROLOGY

A case-control study of community-associated Clostridium difficile infection

(2008) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Physical and chemical factors influencing the germination ofClostridium difficilespores

(2008) L.J. Wheeldon et al.   JOURNAL OF APPLIED MICROBIOLOGY

Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized Patients

(2007) Roger Baxter et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY